Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2022-12-01 00:00:00 ET · period of report 2022-11-29 · accession 0001415889-22-011878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-01 | 2022-11-29 | KNSA | Quart Barry D | Dir | M - OptEx | $1.59 | +22.0K | 22.0K | New | +$34.9K |
| D | 2022-12-01 | 2022-11-29 | KNSA | Quart Barry D | Dir | S - Sale+OE | $16.15 | -22.0K | 0 | -100% | -$354.6K |
| D | 2022-12-01 | 2022-11-29 | KNSA | Quart Barry D | Dir | M - OptEx | $0.00 | -22.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2022-11-29 | M | A | 21,959 | $1.59 | 21,959 | D | — | — | |
| 2 | Common | Class A Common Share | 2022-11-29 | S | D | 21,959 | $16.15 | 0 | D | — | — | (F1) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $16.09 to $16.25. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Class A Common Shares sold at each price. |
| 3 | Derivative | Share Option | 2022-11-29 | M | D | 21,959 | $0.00 | 0 | D | $1.59 · — to 2025-12-15 | 21,959 Class A Common Share | (F2) The option is fully vested and exercisable. |